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Summary
Background Cellulitis can be a difficult diagnosis to make. Furthermore, 31% of
patients admitted from the emergency department with suspected lower-limb cel-
lulitis have been misdiagnosed, with incorrect treatment potentially resulting in
avoidable hospital admission and the prescription of unnecessary antibiotics.
Objectives We sought to identify diagnostic criteria or tools that have been devel-
oped for lower-limb cellulitis.
Methods We conducted a systematic review using Ovid MEDLINE and Embase
databases in May 2018, with the aim of describing diagnostic criteria and
tools developed for lower-limb cellulitis, and we assessed the quality of the
studies identified using the Quality Assessment of Diagnostic Accuracy Studies-
2 tool. We included all types of study that described diagnostic criteria or
tools.
Results Eight observational studies were included. Five studies examined bio-
chemical markers, two studies assessed imaging and one study developed a
diagnostic decision model. All eight studies were considered to have a high risk
for bias in at least one domain. The quantity and quality of available data
was low and results could not be pooled owing to the heterogeneity of the
findings.
Conclusions There is a lack of high-quality publications describing criteria or tools
for diagnosing lower-limb cellulitis. Future studies using prospective designs, val-
idated in both primary and secondary care settings, are needed.
What’s already known about this topic?
• Diagnosing lower-limb cellulitis on first presentation is challenging.
• Approximately one in three patients admitted from the emergency department with
suspected lower-limb cellulitis do not have cellulitis and are given another diagno-
sis on discharge. Consequently, this results in potentially avoidable hospital admis-
sions and the prescription of unnecessary antibiotics.
• There are no diagnostic criteria available for lower-limb cellulitis in the U.K.
What does this study add?
• This systematic review has identified a key research gap in the diagnosis of lower-
limb cellulitis.
• There is a current lack of robustly developed and validated diagnostic criteria or
tools for use in clinical practice.
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Cellulitis is an acute bacterial infection of the dermis and asso-
ciated subcutaneous tissue, with 60% of cases affecting the
lower limb.1 Erysipelas is a form of cellulitis that presents
with more marked superficial inflammation.2
The diagnosis of cellulitis can be challenging, with 31% of
patients who present with suspected lower-limb cellulitis in
the emergency department (ED) subsequently being given a
diagnosis other than cellulitis.3 Routine biochemical and
haematological blood tests and blood cultures are not specific
for cellulitis.4 This results in avoidable hospital admissions and
unnecessary prescriptions of antibiotics.5 Definitive diagnostic
criteria could potentially improve clinical care and also
improve the validity of clinical research on cellulitis by ensur-
ing appropriate case definition.6 However, there are currently
no agreed diagnostic criteria for cellulitis.
Patients with cellulitis commonly present to primary care
services or the ED.7 A recent U.K. cellulitis research priority
setting partnership ranked questions on ‘diagnostic criteria’ as
important for future cellulitis research.8
The aim of this systematic review was to identify and conduct
a critical appraisal of the quality of studies that have developed
or validated diagnostic criteria or tools for lower-limb cellulitis.
We define diagnostic criteria or tools as the inclusion of a
minimum of one variable that has been tested against at least
one clinical feature. In this paper, ‘cellulitis’ refers to lower-
limb cellulitis only. Lower-limb erysipelas is included as it is
clinically indistinguishable from cellulitis.
A preliminary search found no previous systematic reviews
that investigated the development or validation of diagnostic
criteria or tools for cellulitis.
Materials and methods
Protocol and registration
This systematic review was conducted and reported in accor-
dance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement,9 with addi-
tional reference to the Cochrane Handbook for Diagnostic Test
Accuracy Reviews.10 The protocol was registered with PROS-
PERO (http://www.crd.york.ac.uk/PROSPERO, record CRD4
2017080466, November 2017).
Objectives
The primary objective for this review was to identify and
describe diagnostic criteria and tools that have been developed
for lower-limb cellulitis. The secondary objective was to assess
the quality of the studies where diagnostic criteria or tools
were developed.
Eligibility criteria
Studies including patients with lower-limb cellulitis or erysi-
pelas in primary and secondary care, which used diagnostic
criteria or tools for diagnosis, were included.
Inclusion criteria
The following inclusion criteria were applied: any study type
that used diagnostic criteria or tools, in any language, involv-
ing patients of any age, sex or ethnicity, who had lower-limb
cellulitis or erysipelas.
Exclusion criteria
The following articles were excluded: animal studies; labora-
tory in vitro studies; literature and systematic review articles;
expert opinions; conference abstracts; articles that included
only patients with nonlower-limb cellulitis; articles where the
site of cellulitis or erysipelas was not clear; articles where data
from lower-limb cellulitis or erysipelas could not be separated;
articles that used tools to determine ethology; case series with
< 20 patients or those that included < 10 patients with lower-
limb cellulitis or erysipelas.
Database and searches
The following databases were searched on 25 October 2017:
Ovid MEDLINE In-Process & Non-Indexed Citations and Ovid
MEDLINE (1946 to present), Ovid Embase (1980–2017), the
Cochrane Library and Web of Science Core Collection. An
updated search on 22 May 2018 was also undertaken in all
the databases in order to ensure that the results were up-to-
date.
Search strategies for these databases were developed with an
information specialist (D.G.) and in consultation with a cel-
lulitis expert (N.J.L.). Concepts were developed: ‘cellulitis’,
‘diagnosis’ and ‘criteria’, with controlled vocabulary (Medical
Subject Headings terms and Emtree subject headings) and
free-text headings (Table 1). National Institute for Health and
Care Excellence Evidence was also searched using the term
‘cellulitis’.
For grey literature, the first 100 articles (sorted by rele-
vance) on Google Scholar retrieved using the search term ‘di-
agnostic criteria for cellulitis’ were included.
The reference lists of all articles selected for critical appraisal
were screened for additional studies.
Study selection and data extraction
Following the searches, all citations were uploaded to
Covidence (2018) online systematic review management
software,11 with duplicates removed by one reviewer
(M.P.). Title and abstract screening, full-text screening
and data extraction were conducted by independent
reviewers (M.P. and S.L./R.K.A.) using predefined tem-
plates. Any disagreements between reviewers that arose
were resolved through discussion, or with another inde-
pendent reviewer (K.S.T., J.K. or N.J.L.). Data items
sought at the data extraction stage included study aim,
type, population, criteria, funding, sample size, index
test, reference test and key findings.
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Evidence synthesis and risk of bias assessment
All included studies were described in a narrative synthesis.
To evaluate the methodological quality, all studies were
assessed by two reviewers (M.P. and R.K.A.) using signalling
questions in the Quality Assessment of Diagnostic Accuracy
Studies-2 tool,12 with disagreements resolved by a third
reviewer (S.I.L. or E.B.-T.). If the information was not clearly
provided in the study, then the reviewers assessed the sig-
nalling question as ‘unclear’.
For each domain, studies were judged as ‘low risk’ if all
signalling questions were answered ‘yes’, ‘high risk’ if the
answer to at least one signalling question was ‘no’, or ‘un-
clear’ in all other cases.12
Results
Study selection
The PRISMA flowchart shows the results of the complete search
(Fig. 1). A total of 98 papers were included for full-text
screening.5,13–109 Of these, 90 papers were subsequently
excluded,5,21–109 including 20 studies that did not specify the site of
cellulitis5,37,45,46,49,50,52,63,69,70,72,78,81,91,93,95,97,100,102,109 and
Table 1 Search terms used in each database
Database Search terms
Ovid MEDLINE 1. diagnos$.mp. 2. differentiat$.mp. 3. discriminat$.mp. 4. determinin$.mp. 5. confirmat$.mp. 6.
ascertainment.mp. 7. detect$.mp. 8. characteris$.mp. 9. characteriz$.mp. 10. identification.mp. 11.
identify.mp. 12. exp diagnosis/ 13. exp diagnostic imaging/ 14. or/1-13 15. criteria.mp. 16. criterion.mp.
17. classification.mp. 18. clinical feature.mp. 19. clinical features.mp. 20. test$.mp. 21. tool$.mp. 22. imag
$.mp. 23. assay$.mp. 24. accura$.mp. 25. validat$.mp. 26. exp reproducibility of results/ 27.
reproducibility.mp. 28. exp validation studies/ 29. exp validation studies as topic/ 30. exp sensitivity and
specificity/ 31. sensitivity.mp. 32. specificity.mp. 33. exp predictive value of tests/ 34. predictive.mp. 35. or/
15-34 36. and/14 and 35 37. exp diagnostic test, routine/ 38. diagnostic feature.mp. 39. diagnostic
features.mp. 40. exp biomarkers/ 41. biomarker$.mp. 42. marker$.mp. 43. or/37-42 44. or/36 or 43 45.
exp cellulitis/ 46. cellulitis.mp. 47. exp erysipelas/ 48. erysipelas.mp. 49. or/45-48 50. and/44 and 49
Ovid EMBASE 1. diagnos$.mp. 2. differentiat$.mp. 3. discriminat$.mp. 4. determinin$.mp. 5. confirmat$.mp. 6.
ascertainment.mp. 7. detect$.mp. 8. characteris$.mp. 9. characteriz$.mp. 10. identification.mp. 11.
identify.mp. 12. exp diagnosis/ 13. exp diagnostic imaging/ 14. or/1-13 15. criteria.mp. 16. criterion.mp.
17. classification.mp. 18. clinical feature.mp. 19. clinical features.mp. 20. test$.mp. 21. tool$.mp. 22. imag
$.mp. 23. exp assay/ 24. accura*.mp. 25. exp reproducibility/ 26. reproducibility.mp. 27. exp validation
study/ 28. validation studies as topic.mp. 29. validat*.mp. 30. exp ‘‘sensitivity and specificity’’/ 31.
sensitivity.mp. 32. specificity.mp. 33. exp predictive value/ 34. predictive.mp. 35. or/15-34 36. and/14 and
35 37. exp diagnostic test 38. diagnostic feature.mp. 39. diagnostic features.mp. 40. exp biological marker/
41. biomarker$.mp. 42. exp marker/ 43. marker$.mp. 44. or/37-43 45. or/36 or 44 46. exp cellulitis/ 47.
cellulitis.mp. 48. exp erysipelas/ 49. erysipelas.mp. 50. or/46-49 51. and/45 and 50
Cochrane Database
of Systematic Reviews
1.diagnos* 2. differentiat* 3. discriminat* 4. determinin* 5. confirmat* 6. “ascertainment” 7. detect* 8.
characteris* 9. characteriz* 10. “identification” 11. “identify” 12. MeSH descriptor: [Diagnosis] explode all
trees 13. MeSH descriptor: [Diagnostic Imaging] explode all trees 14. #1 or #2 or #3 or #4 or #5 or #6 or
#7 or #8 or #9 or #10 or #11 or #12 or #13 15. “criteria” 16. “criterion” 17. MeSH descriptor:
[Classification] explode all trees 18. “classification” 19. “clinical feature” 20. “clinical features” 21. test* 22.
tool* 23. imag* 24. “assay” 25. accura* 26. MeSH descriptor: [Reproducibility of Results] explode all trees
27. “reproducibility” 28. MeSH descriptor: [Validation Studies as Topic] explode all trees 29. “validation
studies” 30. valid* 31. MeSH descriptor: [Sensitivity and Specificity] explode all trees 32. “sensitivity” 33.
“specificity” 34. “predictive” 35. #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24
or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 36. #14 and #35 37. MeSH
descriptor: [Diagnostic Tests, Routine] explode all trees 38. “diagnostic feature” 39. “diagnostic features” 40.
MeSH descriptor: [Biomarkers] explode all trees 41. biomarker* 42. marker* 43. #37 or #38 or #39 or #40
or #41 or#42 44. #36 or #43 45. MeSH descriptor: [Cellulitis] explode all trees 46. “cellulitis” 47. MeSH
descriptor: [Erysipelas] explode all trees 48. “erysipelas” 49. #45 or #46 or #47 or #48 50. #44 and #49
Web of Science
Core Collection
1.TS = diagnos* 2. TS = differentiat* 3. TS = discriminat* 4. TS = determinin* 5. TS = confirmat* 6. TS =
ascertainment 7. TS = detect* 8. TS = characteris* 9. TS = characteriz* 10. TS = identification 11. TS =
identify 12. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 13. TS = criterion 14.
TS = classification 15. TS = “clinical feature” 16. TS = “clinical features” 17. TS = test* 18. TS = tool* 19. TS
= imag* 20. TS = assay 21. TS = accura* 22. TS = reproducibility 23. TS = valid* 24. TS = “validation
studies” 25. TS = sensitivity 26. TS = specificity 27. TS = predictive 28. #13 or #14 or #15 or #16 or#17
or#18 or#19 or #20 or #21 or #22 or#23 or #24 or #25 or #26 or #27 29. #12 and #28 30. TS =
“diagnostic features” 31. TS = “diagnostic feature” 32. TS = biomarker* 33. TS = marker* 34. #30 or #31
or #32 or #33 35. #29 or #34 36. TS = cellulitis 37. TS = erysipelas 38. #36 or #37 39. #35 and #38
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eight studies that did not separate the results of lower-limb cel-
lulitis from other sites.26,29,55,87,90,98,99,107 Eight studies were
included for data extraction.13–20
Study characteristics
The characteristics of all eight included studies are summa-
rized in Table 2. Raff et al. explored lower-limb cellulitis as
the main pathology.18 Seven studies included patients with
lower-limb cellulitis as a comparison group, in which cellulitis
and other diagnoses were compared.13–17,19,20
Six studies were case–control studies,13–16,19,20 one study
was a cohort study17 and there was one cross-sectional
study.18 The most common setting was the ED (three
studies).17–20 The studies were conducted in six different
countries. Kato et al. did not include exclusion criteria.14
Reference tests
The reference test for cellulitis was a clinical diagnosis in
seven studies,14–20 with a bone scan used by Fleischer et al.13
However, only Rabuka et al. clearly stated the specialty of the
physician who made the cellulitis diagnosis.17 Two studies fol-
lowed up patients for up to 30 days in order to determine the
final diagnosis.18,19
Index tests
Studies where cellulitis was the main pathology
Predictive score In a study to compare cellulitis with pseudocel-
lulitis, Raff et al. developed an ALT-70 score (7 points) that
assessed the following: asymmetry (unilateral involvement, 3
points); leucocytosis (white blood cell count ≥ 10 000 lL1,
1 point); tachycardia (heart rate ≥ 90 beats per minute, 1
point); and age ≥ 70 years (2 points).18 An ALT-70 score
below 3 had a > 833% likelihood of pseudocellulitis – an
alternative diagnosis to cellulitis, and a score above 4 had a >
822% likelihood of cellulitis.18
Studies where cellulitis was used as a comparator
Clinical features One study comparing cellulitis and osteomyeli-
tis among patients with diabetes found that a temperature
higher than 372 °C was predictive of osteomyelitis;13 how-
ever, Malabu et al. found no significant differences in clinical
parameters between these groups.15
Rabuka et al. showed that distinct margins of erythema
were seen in six (8%) patients with cellulitis vs. 0 (0%) in
patients with deep vein thrombosis (DVT) (P = 0008).17
However, when comparing erysipelas with DVT, Rast et al.
(n = 14 865) (n = 100)
(n = 98)
(n = 8)
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Fig 1. Preferred reporting items for systematic reviews and meta-analyses flowchart of literature search and study selection.
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found no significant differences between any physical
signs.19
Biochemical and haematological tests In a study comparing cellulitis
with acute gout, delta neutrophil index (immature granulocyte
count) > 17% was the only independent factor for predicting
cellulitis (P = 0002), compared with white blood cell (WBC)
count (P = 041), C-reactive protein (CRP) (P = 0277) and
procalcitonin (PCT) (P = 0122).16 Creatine kinase (CK) was
significantly higher in all cases of necrotizing fasciitis (NF)
compared with cellulitis.14
Malabu et al. found that in patients with diabetes, haemo-
globin (P < 00001) and haematocrit (P < 00001) were
higher in patients with cellulitis than in patients with
osteomyelitis.15 However, erythrocyte sedimentation rate
(ESR) (P < 0001),13,15 CRP (P < 0001),13 platelet count (P <
001),15 WBC (P < 005)15 and red cell width (P < 005)15
were higher in patients with osteomyelitis than in patients
with cellulitis.15
In one study, PCT concentrations in patients with erysipelas
were compared with PCT concentrations in patients with
DVT.19 Patients with erysipelas had significantly higher con-
centrations of PCT (P = 0001). At a PCT threshold of > 025
lg L1, the specificity and positive predictive value for erysi-
pelas was 100%. No significant differences were seen between
the two groups with regard to CRP concentrations (P = 020)
and WBC counts (P = 014).19
In contrast, Rabuka et al. found a raised WBC in 213% of
patients with cellulitis vs. 50% of patients with DVT (P =
0038).17 This study also found that CK was higher in the cel-
lulitis group compared with the DVT group.17
Imaging In a study comparing cellulitis with lymphoedema
using computed tomography (CT) scanning, Shin et al.
found specific features that were more frequently associated
with cellulitis.20 These features included fluid collection (P
= 0009), fascial enhancement (P = 0043), inguinal
lymph node enlargement at the affected side (P < 0001)
and inguinal lymph node medullary fat obliteration (P <
0001).
Rabuka et al. examined ultrasound imaging in patients with
a presentation suggestive of cellulitis, with 72 patients (80%)
diagnosed with cellulitis after having a negative duplex scan.17
Methodological quality
Risk of bias
The risk of bias for patient selection was high for all eight
studies; six used a case–control method13–16,19,20 and the
exclusion criteria were not deemed appropriate in two stud-
ies as they excluded patients who were more difficult to
diagnose (Table 3 and Fig. 2).17,18 The study by Shin et al.
had a low risk of bias for the index test, as it included a
prespecified threshold,20 whereas the other seven studies did
not.13–19 The reference standard used in the study by Rabuka
et al. was considered high risk as some patients received the
reference test after the index test,17 thereby increasing the
risk of observer bias. The risk was unclear in the remaining
seven studies as it was not possible to determine whether
the diagnosis of cellulitis was accurate. The flow of timing
was unclear in seven studies,14–20 as it was not stated
whether all the patients received the same reference standard
test. The flow of timing described in the study by Fleischer
et al. was considered high risk as not all the patients were
analysed.13
Concerns regarding applicability
With regard to patient selection and reference standard appli-
cability, all eight studies included patients who had already
been diagnosed with cellulitis and we cannot definitively state
that the correct diagnosis had been made. However, five stud-
ies were high risk for patient selection bias as they included
either a rare differential diagnosis for cellulitis, i.e. osteomyeli-
tis and NF,13–15 or included only patients with initially sus-
pected DVT.17,20 The index test in four studies was judged to
be high risk; two studies included only investigations for dia-
betic foot ulcers13,15 and two studies included imaging for
suspected DVT.17,20
Table 3 Risk of bias assessment using the Quality Assessment of Diagnostic Accuracy Studies-2 diagnostic accuracy critical appraisal tool showing
risk of bias for each domain for individual studies
Study
Risk of bias Concerns regarding applicability
Patient
selection Index test
Reference
standard
Patient flow
and timing
Patient
selection Index test
Reference
standard
Fleischer et al.13 High High Unclear High High High Unclear
Kato et al.14 High High Unclear Unclear High Low Unclear
Malabu et al.15 High High Unclear Unclear High High Unclear
Pyo et al.16 High High Unclear Unclear Unclear Low Unclear
Rabuka et al.17 High High High Unclear High High Unclear
Raff et al.18 High High Unclear Unclear Unclear Low Unclear
Rast et al.19 High High Unclear Unclear Unclear Low Unclear
Shin et al.20 High Low Unclear Unclear High High Unclear
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Excluded studies
Of the excluded studies, 20 did not specify the site of celluli-
tis. Of these, David et al. developed a visually based computer-
ized diagnostic decision support system.5 Pallin et al. studied
PCT and HLA-DQA1 expression,81 Kini et al. investigated ESR52
and three other studies examined the Laboratory Risk Indicator
for Necrotizing Fasciitis (LRINEC) score.63,78,109 Six studies
explored radio nucleotide or bone imaging,37,45,69,70,93,102
five examined magnetic resonance imaging (MRI)49,50,91,95,97
and two considered ultrasound imaging in the paediatric set-
ting.46,72 Smirnova et al. investigated antibodies in erysipe-
las.100
Eight studies did not present the results of lower-limb cel-
lulitis separately. Of these, Rahmouni et al. examined the use
of MRI in cellulitis90 and Chao et al. utilized ultrasound imag-
ing for soft-tissue infections in the paediatric population.29
Bonnetblanc et al. investigated a modification of the LRINEC
score,26 two studies focused on multiple laboratory and clini-
cal markers98,99 and Radkevich et al. investigated coagulable
factors.87 Wang et al. discussed tissue oxygen saturation moni-
toring107 and Ko et al. examined the use of thermal imaging
cameras.54,55
Discussion
We found no robustly developed and validated diagnostic
tools or criteria for lower-limb cellulitis. A variety of potential
tools have been explored so far, including biochemical tests,
imaging, predictive scoring and clinical features. However, in
seven of the eight included studies, cellulitis was not the main
pathology of interest and was used as a comparator. Three
studies compared cellulitis with rare differential diagnoses,
such as osteomyelitis, which provide limited clinical applica-
bility. This diversity in the tools explored emphasizes the diffi-
culty in making a correct diagnosis on first presentation.
All eight included studies identified in this review were
observational studies.16–19 The sample sizes were small, with
only two studies including more than 100 patients with cel-
lulitis.16,18 No criteria or tools have been subsequently vali-
dated in a large prospective study.
Despite cellulitis being a common presentation in commu-
nity settings, all the tools identified to date have been devel-
oped and tested in secondary care, with limited evidence of
validity or applicability in community settings. No study stated
that the gold standard reference for clinical diagnosis was a
board certified dermatologist or other specialist with cellulitis
expertise. Only one study clearly stated who made the celluli-
tis diagnosis.17
All the tools developed to date can be accessed by secondary
care, are already available and, with the exception of CT imag-
ing, are inexpensive. The severity of cellulitis is likely to be
worse in secondary care. However, none of these tools can be
used until they are validated in higher-quality studies.
Three studies included rare pathologies that provide very
limited clinical relevance as they are not common misdiag-
noses of cellulitis.110 Blood tests need to be interpreted with
caution, as ESR, CRP and WBC count are nondiscriminatory
markers, but can be used to guide a clinician when the dif-
ferential diagnoses have been narrowed. High levels of these
markers can also help point towards rarer pathologies such
as NF. Only one study included paediatric patients,20 there-
fore findings cannot be applied to this under-researched
population.
This is the first systematic review that aimed to identify
diagnostic criteria or tools developed for lower-limb cellulitis.
The key strength of this review is the comprehensive search
strategy used, which was supported by an experienced infor-
mation specialist. The focus of this review was lower-limb cel-
lulitis and therefore, if the site of cellulitis was not specified
or a study did not present the results of lower-limb cellulitis
separately, then the study was excluded.
The limitations of this review stem from the number and
quality of the studies included. Data could not be pooled as
the index tests were not comparable. Also, 28 papers were
excluded as the site of cellulitis was not specified or the results
for lower-limb cellulitis were not separated. These papers did
include diagnostic criteria or tools that need to be further
evaluated. Owing to time constraints, only the first 100 results
on Google Scholar were included.
In conclusion, this systematic review has identified an
important research gap in the diagnosis of lower-limb
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Patient selection (domain 1)
Index test (domain 2)
Reference test (domain 3)
Flow of patients (domain 4)
QUADAS-2: Percentage of studies with a high,
unclear or low risk of bias
High risk Unclear risk Low risk
Fig 2. Graph showing the percentage of studies with a low, high or unclear risk of bias for each of the four domains. QUADAS, Quality
Assessment of Diagnostic Accuracy Studies.
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cellulitis. There is currently insufficient evidence available to
support the validity of any diagnostic criteria or tools that
have been developed for lower-limb cellulitis. As such, their
utility for clinical practice or research remains unclear. Future
studies should employ prospective designs, using diagnosis by
board certified specialists with cellulitis expertise as the refer-
ence diagnostic standard and should be validated in both pri-
mary and secondary care settings. To gain a better
understanding of what ought to be included in diagnostic cri-
teria or tools, qualitative research that includes input from a
range of healthcare professionals and patients with experience
of managing lower-limb cellulitis should be carried out.
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